Clinical Trials Directory

Trials / Completed

CompletedNCT02206945

Neurofeedback for Obsessive-Compulsive Disorder (OCD)

Neurofeedback of Activity in the Orbitofrontal Cortex for OCD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to train patients with obsessive-compulsive disorder to control a region of their brain that has been associated with their symptoms. Patients in the experimental group will be given direct feedback regarding activity in this brain area while they are undergoing functional magnetic resonance imaging (fMRI) scanning, and will try to learn to control activity in the region during these feedback sessions. A separate group of patients will be given a control form of feedback that we do not believe can have clinical benefits. Our primary hypothesis is that the neurofeedback training will reduce OCD symptoms more than the control feedback.

Detailed description

Original study design recruiting controls who were matched to the experimental group was changed to a randomized design prior to enrollment of the first participant.

Conditions

Interventions

TypeNameDescription
BEHAVIORALneurofeedbackSubject provided with feedback of activity in target brain area in the form of a line graph. Cued to try to make the line go up at certain times and down at other times.
BEHAVIORALcontrol feedbackSubject provided with a control/placebo type of feedback in the form of a line graph. Cued to try to make the line go up at certain times and down at other times.

Timeline

Start date
2015-07-01
Primary completion
2021-11-01
Completion
2021-11-01
First posted
2014-08-01
Last updated
2022-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02206945. Inclusion in this directory is not an endorsement.